Denmark said Saturday that one person died and another fell seriously ill after taking the AstraZeneca COVID-19 vaccine, triggering the country to continue its suspension of the treatment.

The two patients were both hospital workers and had received the AstraZeneca vaccine less than 14 days prior to ending up being ill with blood embolisms and cerebral hemorrhaging, Reuters reported.

Denmark’s statement comes amidst worldwide concerns that the AstraZeneca vaccine, which was created by British-Swedish pharmaceutical business AstraZeneca and the University of Oxford, might be connected to fatal brain blood clotting in some clients.
On Saturday, Denmark stated someone had actually passed away and another fell seriously ill after receiving the AstraZeneca COVID-19 vaccine. Here, a medical worker prepares a syringe of the AstraZeneca vaccine in Copenhagen on February 11.
LISELOTTE SABROE/Ritzau Scanpix/AFP/Getty Images

In reaction to the pause, various scientific bodies– consisting of the World Health Organization, the European Medicines Firm (EMA) and the Medicines and Healthcare Products Regulatory Agency in the U.K.– stressed that there is no proof of a link between the vaccine and blood-clotting events.

On Thursday, the EMA released an investigative report of the vaccine in which it determined its use to be “safe and efficient.”

” The committee has actually pertained to a clear scientific conclusion. This is a safe and effective vaccine,” EMA executive director Emer Cooke said.

Nevertheless, Cooke included that the company could not definitively rule out the link in between blood clot and the vaccine. Rather, she firmly insisted that the advantages of getting the shot far outweigh the potential threats.

” What the committee has actually therefore suggested is awareness of these possible risks. Making certain that they’re consisted of in the item details,” she stated. “Accentuating these possible conditions and supplying info to healthcare experts and immunized people will help to identify and reduce any possible negative effects.”

The EMA announcement prompted a number of European nations, including Germany and France, to renew the vaccine. On Friday, Denmark, along with Sweden and Norway, said that they will need more time to choose whether to reverse the suspension.

AstraZeneca on Saturday decreased to comment on the new cases in Denmark, but instead pointed Newsweek to a declaration in which it stated that “vaccine security is paramount” to the company.

” We welcome the regulators’ decisions which verify the frustrating advantage of our vaccine in stopping the pandemic. We rely on that, after the regulators’ mindful decisions, vaccinations can once again resume across Europe,” the statement included.

Newsweek contacted the Danish Ministry of Health for additional remark, but did not hear back in time for publication.

LEAVE A REPLY

Please enter your comment!
Please enter your name here